Literature DB >> 10361787

Psychiatric comorbidity among adolescents with substance use disorders: findings from the MECA Study.

D B Kandel1, J G Johnson, H R Bird, M M Weissman, S H Goodman, B B Lahey, D A Regier, M E Schwab-Stone.   

Abstract

OBJECTIVE: To investigate the extent to which adolescents in the community with current substance use disorders (SUD) experience co-occurring psychiatric disorders.
METHOD: Diagnostic data were obtained from probability samples of 401 children and adolescents, aged 14 to 17 years, and their mothers/caretakers, who participated in the Methods for the Epidemiology of Child and Adolescent Mental Disorders (MECA) Study.
RESULTS: The rates of mood and disruptive behavior disorders are much higher among adolescents with current SUD than among adolescents without SUD. Comparison with adult samples suggests that the rates of current comorbidity of SUD with psychiatric disorders are the same among adolescents as adults, and lower for lifetime disruptive disorders/antisocial personality disorder among adolescents than adults.
CONCLUSIONS: The high rate of coexisting psychiatric disorders among adolescents with SUD in the community needs to be taken into account in prevention and treatment programs.

Entities:  

Mesh:

Year:  1999        PMID: 10361787     DOI: 10.1097/00004583-199906000-00016

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  57 in total

1.  Diagnostic Profiles among Urban Adolescents with Unmet Treatment Needs: Comorbidity and Perceived Need for Treatment.

Authors:  Aaron Hogue; Sarah Dauber
Journal:  J Emot Behav Disord       Date:  2013-03-01

2.  Racial/ethnic variations in substance-related disorders among adolescents in the United States.

Authors:  Li-Tzy Wu; George E Woody; Chongming Yang; Jeng-Jong Pan; Dan G Blazer
Journal:  Arch Gen Psychiatry       Date:  2011-11

3.  Dual and multiple diagnosis among substance using runaway youth.

Authors:  Natasha Slesnick; Jillian Prestopnik
Journal:  Am J Drug Alcohol Abuse       Date:  2005       Impact factor: 3.829

4.  The differential impact of risk factors on illicit drug involvement in females.

Authors:  Arpana Agrawal; Charles O Gardner; Carol A Prescott; Kenneth S Kendler
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2005-06       Impact factor: 4.328

5.  Development and validation of the GAIN Short Screener (GSS) for internalizing, externalizing and substance use disorders and crime/violence problems among adolescents and adults.

Authors:  Michael L Dennis; Ya-Fen Chan; Rodney R Funk
Journal:  Am J Addict       Date:  2006

6.  Profiles of current disruptive behavior: association with recent drug consumption among adolescents.

Authors:  Carla L Storr; Veronica H Accornero; Rosa M Crum
Journal:  Addict Behav       Date:  2006-05-19       Impact factor: 3.913

7.  12-step participation and outcomes over 7 years among adolescent substance use patients with and without psychiatric comorbidity.

Authors:  Felicia W Chi; Stacy Sterling; Cynthia I Campbell; Constance Weisner
Journal:  Subst Abus       Date:  2013       Impact factor: 3.716

Review 8.  The complicated relationship between attention deficit/hyperactivity disorder and substance use disorders.

Authors:  Courtney A Zulauf; Susan E Sprich; Steven A Safren; Timothy E Wilens
Journal:  Curr Psychiatry Rep       Date:  2014-03       Impact factor: 5.285

9.  Diagnostic transitions from childhood to adolescence to early adulthood.

Authors:  William E Copeland; Carol E Adair; Paul Smetanin; David Stiff; Carla Briante; Ian Colman; David Fergusson; John Horwood; Richie Poulton; E Jane Costello; Adrian Angold
Journal:  J Child Psychol Psychiatry       Date:  2013-03-02       Impact factor: 8.982

10.  Early-onset depressive disorders predict the use of addictive substances in adolescence: a prospective study of adolescent Finnish twins.

Authors:  Elina Sihvola; Richard J Rose; Danielle M Dick; Lea Pulkkinen; Mauri Marttunen; Jaakko Kaprio
Journal:  Addiction       Date:  2008-10-08       Impact factor: 6.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.